Which AI drug-discovery companies are about to need our products, and when?
The brief
The client's BD desk sells genes, proteins, antibodies and manufacturing capacity to biotech. Its fastest-growing buyers are AI drug-discovery companies, which buy little while they are software and a lot the moment they cross into the clinic. With more than 1,000 of them worldwide, the team needed to know each month which ones had just crossed, and why.
Headline numbersSix signal families
The month in one pageRanked by heat
Clinic crossingsHeat by sub-vertical
Tagged by business lineWork these first991 companies on the radar, 433 moved, 1,003 buying signals and 131 high-intent triggers. Client name blurred.
What we built
- A radar of 991 AI drug-discovery and adjacent companies, tagged by sub-vertical and by which of the client's two business lines each one fits.
- Six signal families read as they happen: capital and deals, regulatory and pipeline, partnerships and wins, product launches, growth and hiring, recognition.
- A weighted heat score that ranks companies by buying intent, with capital, clinical and partnership events counting most.
- An AI market read each month, then one page per signal family on what it means for the BD desk.
- A heat map of 14 sub-verticals that shows where demand is building, from multi-omics to radioligand therapy.
What the signals showed
IND clearances and first-in-human starts: the moment an in-silico company has to manufacture, and the clearest buying trigger in the data.
The largest category. Many sat on the client's own tracked list, so existing accounts were visibly active.
Partnership- and product-heavy companies that consume reagents and libraries at scale.
How it ran
- SetupProfile
Sub-verticals, business lines and buying triggers agreed.
- Always onRead
The agent reads six signal families across 991 companies.
- MonthlyRadar
A ranked 13-page brief with an AI market read.
- Every weekAct
Top movers go to the right business line with a reason to call.
What changed
The BD desk starts each month with a ranked list: who crossed into the clinic, who raised, who partnered, and which business line should call. Capital and regulatory signals are worked first.
Plan my Signal Agent